IL15 and leukemia: Similar to our findings in peripheral blood (Figure 3E), the mice treated with CD123-ENG.IL15 T-cells also had a significantly decreased leukemia burden and a greater frequency of human T-cells (total and CD123-ENG.IL15 T-cells) in the liver, spleen, and BM compared to other treatment groups (Figures 3F, G; S5).